Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 94Terminated 37Recruiting 31Active not recruiting 22Unknown 17Withdrawn 5Suspended 3Not yet recruiting 3No longer available 1Enrolling by invitation 1Approved for marketing 1

Sponsor Class

OTHER 1NETWORK 1INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Genitourinary 50Dermatologic 5Head & Neck 4Gynecologic 3Breast 3Thoracic 2Sarcoma 2Gastrointestinal 2Lymphoid 1Endocrine 1

Conditions

Breast Neoplasms 549Triple Negative Breast Neoplasms 84Neoplasms 20Lung Neoplasms 16Colorectal Neoplasms 16Neoplasm Metastasis 15Advanced Breast Cancer 15Prostatic Neoplasms 13Motor Activity 13HER2-positive Breast Cancer 12Carcinoma, Non-Small-Cell Lung 12Carcinoma, Intraductal, Noninfiltrating 11Breast Cancer Lymphedema 11Stomach Neoplasms 10Anxiety Disorders 10Endometrial Neoplasms 9Uterine Cervical Neoplasms 8Ovarian Neoplasms 8Depression 8Pain 7Cardiotoxicity 7Brain Neoplasms 7Pain, Postoperative 6Melanoma 6Lymphedema 6Head and Neck Neoplasms 6Colonic Neoplasms 6Pancreatic Neoplasms 5Liver Neoplasms 5Anatomic Stage I Breast Cancer AJCC v8 5

Interventions

fludarabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × Carcinoma, Renal Cell × Breast × Clear all
NCT07297667 2026-05-12

GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours

Canadian Cancer Trials Group

Phase 1 Not yet recruiting
30 enrolled
BreastGenitourinarySarcoma

Carcinoma, Renal Cell, Sarcoma, Alveolar Soft Part, Triple Negative Breast Neoplasms

NCT07246759 2025-11-24

NEUTROFLOW

OncoHost Ltd.

Not yet recruiting
600 enrolled
BreastDermatologicGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Triple Negative Breast Neoplasms

NCT06976021 2025-05-16

INTROSPECTION

Maria Sklodowska-Curie National Research Institute of Oncology

Phase 2 Not yet recruiting
60 enrolled
BreastDermatologicGenitourinaryGynecologic

Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Melanoma, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡